Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system - T46
Excludes1: It indicates that the conditions described by two codes cannot occur together in the same patient. These codes are mutually exclusive.
Type 1 Excludes:
- poisoning by, adverse effect of and underdosing of metaraminol (T44.4)
The seventh character in ICD-10-CM is an essential component that adds specificity to diagnosis codes by indicating aspects like the encounter type, stage, or other relevant clinical details.
Category SevenChr Note:
- The appropriate 7th character is to be added to each code from category T46
These ranges represents subcategories of Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system. The "T46" signifies that these are the diseases within this broad category.
Codes:
- T46.0 - Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
- T46.0X - Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
- T46.0X1 - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional)
- T46.0X2 - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm
- T46.0X3 - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault
- T46.0X4 - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined
- T46.0X5 - Adverse effect of cardiac-stimulant glycosides and drugs of similar action
- T46.0X6 - Underdosing of cardiac-stimulant glycosides and drugs of similar action
- T46.1 - Poisoning by, adverse effect of and underdosing of calcium-channel blockers
- T46.1X - Poisoning by, adverse effect of and underdosing of calcium-channel blockers
- T46.1X1 - Poisoning by calcium-channel blockers, accidental (unintentional)
- T46.1X2 - Poisoning by calcium-channel blockers, intentional self-harm
- T46.1X3 - Poisoning by calcium-channel blockers, assault
- T46.1X4 - Poisoning by calcium-channel blockers, undetermined
- T46.1X5 - Adverse effect of calcium-channel blockers
- T46.1X6 - Underdosing of calcium-channel blockers
- T46.2 - Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs, not elsewhere classified
- T46.2X - Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs
- T46.2X1 - Poisoning by other antidysrhythmic drugs, accidental (unintentional)
- T46.2X2 - Poisoning by other antidysrhythmic drugs, intentional self-harm
- T46.2X3 - Poisoning by other antidysrhythmic drugs, assault
- T46.2X4 - Poisoning by other antidysrhythmic drugs, undetermined
- T46.2X5 - Adverse effect of other antidysrhythmic drugs
- T46.2X6 - Underdosing of other antidysrhythmic drugs
- T46.3 - Poisoning by, adverse effect of and underdosing of coronary vasodilators
- T46.3X - Poisoning by, adverse effect of and underdosing of coronary vasodilators
- T46.3X1 - Poisoning by coronary vasodilators, accidental (unintentional)
- T46.3X2 - Poisoning by coronary vasodilators, intentional self-harm
- T46.3X3 - Poisoning by coronary vasodilators, assault
- T46.3X4 - Poisoning by coronary vasodilators, undetermined
- T46.3X5 - Adverse effect of coronary vasodilators
- T46.3X6 - Underdosing of coronary vasodilators
- T46.4 - Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
- T46.4X - Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
- T46.4X1 - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional)
- T46.4X2 - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm
- T46.4X3 - Poisoning by angiotensin-converting-enzyme inhibitors, assault
- T46.4X4 - Poisoning by angiotensin-converting-enzyme inhibitors, undetermined
- T46.4X5 - Adverse effect of angiotensin-converting-enzyme inhibitors
- T46.4X6 - Underdosing of angiotensin-converting-enzyme inhibitors
- T46.5 - Poisoning by, adverse effect of and underdosing of other antihypertensive drugs
- T46.5X - Poisoning by, adverse effect of and underdosing of other antihypertensive drugs
- T46.5X1 - Poisoning by other antihypertensive drugs, accidental (unintentional)
- T46.5X2 - Poisoning by other antihypertensive drugs, intentional self-harm
- T46.5X3 - Poisoning by other antihypertensive drugs, assault
- T46.5X4 - Poisoning by other antihypertensive drugs, undetermined
- T46.5X5 - Adverse effect of other antihypertensive drugs
- T46.5X6 - Underdosing of other antihypertensive drugs
- T46.6 - Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
- T46.6X - Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
- T46.6X1 - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional)
- T46.6X2 - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm
- T46.6X3 - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault
- T46.6X4 - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined
- T46.6X5 - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs
- T46.6X6 - Underdosing of antihyperlipidemic and antiarteriosclerotic drugs
- T46.7 - Poisoning by, adverse effect of and underdosing of peripheral vasodilators
- T46.7X - Poisoning by, adverse effect of and underdosing of peripheral vasodilators
- T46.7X1 - Poisoning by peripheral vasodilators, accidental (unintentional)
- T46.7X2 - Poisoning by peripheral vasodilators, intentional self-harm
- T46.7X3 - Poisoning by peripheral vasodilators, assault
- T46.7X4 - Poisoning by peripheral vasodilators, undetermined
- T46.7X5 - Adverse effect of peripheral vasodilators
- T46.7X6 - Underdosing of peripheral vasodilators
- T46.8 - Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
- T46.8X - Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
- T46.8X1 - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional)
- T46.8X2 - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm
- T46.8X3 - Poisoning by antivaricose drugs, including sclerosing agents, assault
- T46.8X4 - Poisoning by antivaricose drugs, including sclerosing agents, undetermined
- T46.8X5 - Adverse effect of antivaricose drugs, including sclerosing agents
- T46.8X6 - Underdosing of antivaricose drugs, including sclerosing agents
- T46.9 - Poisoning by, adverse effect of and underdosing of other and unspecified agents primarily affecting the cardiovascular system
- T46.90 - Poisoning by, adverse effect of and underdosing of unspecified agents primarily affecting the cardiovascular system
- T46.901 - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional)
- T46.902 - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm
- T46.903 - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault
- T46.904 - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined
- T46.905 - Adverse effect of unspecified agents primarily affecting the cardiovascular system
- T46.906 - Underdosing of unspecified agents primarily affecting the cardiovascular system
- T46.99 - Poisoning by, adverse effect of and underdosing of other agents primarily affecting the cardiovascular system
- T46.991 - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional)
- T46.992 - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm
- T46.993 - Poisoning by other agents primarily affecting the cardiovascular system, assault
- T46.994 - Poisoning by other agents primarily affecting the cardiovascular system, undetermined
- T46.995 - Adverse effect of other agents primarily affecting the cardiovascular system
- T46.996 - Underdosing of other agents primarily affecting the cardiovascular system